Dana dhuwit perusahaan: XOMA Corp (XOMA)

Simbol resmi perusahaan XOMA Royalty (XOMA)

XOMA Royalty (XOMA) revenues depend on the results of third-party tests and patent expiration dates. The cash flow history demonstrates a pivot driven by the acquisition of rights to early-stage drugs and the absence of R&D expenses, which maximizes margins. The current liquidity level 0.10 shows the current value of the metric, confirming the business's financial stability under passive asset management.

XOMA - Volume dana dhuwit perusahaan XOMA Royalty Corporation ing rentang 04.07.2022 - 25.07.2026

Rincian metrik keuangan lan pasar xoma.com (XOMA)

- nilai saham lan prakiraan konsensus rega:
Analisis kabeh metrik perusahaan:XOMA Royalty Corporation XOMA
Produk mawa merek XOMA Royalty

This metric measures the total volume of liquid assets, determining the issuer's ability to service obligations without seeking external financing. For XOMA Royalty (XOMA), maintaining reserves is critical during the aggressive acquisition of rights to various biotechnological drugs. By analyzing the cash on hand, an investor assesses the sustainability of the royalty portfolio diversification strategy. High liquidity minimizes default risk, confirming the asset's conservative safety profile.